Search alternatives:
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), rc decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), rc decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
40061
Table 1_Targeting nail psoriasis: IL-17A inhibitors demonstrate site-specific superiority over IL-23 inhibitor in a 24-week dermoscopy-guided real-world cohort.docx
Published 2025“…</p>Results<p>(1) By week 24, PASI, BSA, DLQI and NAPSI scores had significantly decreased from baseline in all groups (P<0.001). (2) By week 24: SEC, IXE, and GUS groups saw nail matrix NAPSI score improvements of 65.9%, 60.5%, and 51.5%, with 68%, 55%, and 30% achieving NAPSI 60; Nail bed NAPSI score improvements were 58.8%, 68.6%, and 65.8%, with 28%, 65%, and 40% achieving NAPSI 60; Total NAPSI score improvements were 62.7%, 64.6%, and 53.7%, with 44%, 70%, and 30% achieving NAPSI 60. (3) All patients in the SEC and IXE groups achieved PASI 75, compared to 85% in the GUS group. …”
-
40062
Image_5_Transcriptomic and Epigenomic Dynamics of Honey Bees in Response to Lethal Viral Infection.jpeg
Published 2020“…Israeli Acute Paralysis Virus (IAPV) is emerging as a model virus since its association with severe colony losses. …”
-
40063
Table_5_Transcriptomic and Epigenomic Dynamics of Honey Bees in Response to Lethal Viral Infection.XLSX
Published 2020“…Israeli Acute Paralysis Virus (IAPV) is emerging as a model virus since its association with severe colony losses. …”
-
40064
Tumor growth after tumor challenge in C57BL/6 mice immunized with recMAGE-A3 formulated with different immunostimulants.
Published 2014“…<p>The mice (n = 5) were immunized with recMAGE-A3 (10 µg of antigen) formulated with different immunostimulants and challenged with TC1-MAGE-A3 cells. …”
-
40065
Data_Sheet_1_A Novel Third Wave Contextual Approach of Positive Behavior Support in School for Adolescent at High Psychosocial Risk: Rationale, Feasibility, and First Pilot Outcome...
Published 2019“…Third wave cognitive-behavioral interventions are increasingly becoming the chosen instruments to support psychological intervention for young people and adolescents. In this study, we aim to test the feasibility and the adequacy of the outcome measures of an intervention for adolescents at high psychosocial risk, using a modified Discoverer, Noticer, Advisor and Values (DNA-V) protocol aimed at increasing flexible and positive values. …”
-
40066
Development of Low-Molecular-Weight Compounds Targeting the Cancer-Associated KLF5 Transcription Factor
Published 2022“…Krüppel-like factor 5 (KLF5) is a potential target for anticancer drugs. …”
-
40067
Development of Low-Molecular-Weight Compounds Targeting the Cancer-Associated KLF5 Transcription Factor
Published 2022“…Krüppel-like factor 5 (KLF5) is a potential target for anticancer drugs. …”
-
40068
Development of Low-Molecular-Weight Compounds Targeting the Cancer-Associated KLF5 Transcription Factor
Published 2022“…Krüppel-like factor 5 (KLF5) is a potential target for anticancer drugs. …”
-
40069
Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer
Published 2024“…Here, we reported a novel compound corallorazine D from <i>Nocardiopsis</i> sp. …”
-
40070
Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer
Published 2024“…Here, we reported a novel compound corallorazine D from <i>Nocardiopsis</i> sp. …”
-
40071
Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer
Published 2024“…Here, we reported a novel compound corallorazine D from <i>Nocardiopsis</i> sp. …”
-
40072
Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer
Published 2024“…Here, we reported a novel compound corallorazine D from <i>Nocardiopsis</i> sp. …”
-
40073
Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer
Published 2024“…Here, we reported a novel compound corallorazine D from <i>Nocardiopsis</i> sp. …”
-
40074
Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer
Published 2024“…Here, we reported a novel compound corallorazine D from <i>Nocardiopsis</i> sp. …”
-
40075
Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer
Published 2024“…Here, we reported a novel compound corallorazine D from <i>Nocardiopsis</i> sp. …”
-
40076
Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer
Published 2024“…Here, we reported a novel compound corallorazine D from <i>Nocardiopsis</i> sp. …”
-
40077
Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer
Published 2024“…Here, we reported a novel compound corallorazine D from <i>Nocardiopsis</i> sp. …”
-
40078
Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer
Published 2024“…Here, we reported a novel compound corallorazine D from <i>Nocardiopsis</i> sp. …”
-
40079
Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer
Published 2024“…Here, we reported a novel compound corallorazine D from <i>Nocardiopsis</i> sp. …”
-
40080
Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer
Published 2024“…Here, we reported a novel compound corallorazine D from <i>Nocardiopsis</i> sp. …”